"Gonadotropin-resistant ovaries" syndrome in association with secondary amenorrhea.
D000328:Adult; D000568:Amenorrhea / Q000209:etiology*; D000728:Androgens / Q000097:blood; D002996:Clomiphene / Q000627:therapeutic use; D003864:Depression, Chemical; D003907:Dexamethasone; D004958:Estradiol / Q000097:blood / Q000627:therapeutic use; D004970:Estrone / Q000097:blood; D005246:Feedback; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006062:Gonadotropins / Q000378:metabolism*; D006801:Humans; D006914:Hydroxysteroids / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D007247:Infertility, Female / Q000209:etiology; D010535:Laparoscopy; D007986:Luteinizing Hormone / Q000097:blood; D008797:Metyrapone; D010049:Ovarian Diseases / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011863:Radioimmunoassay; D012712:Serum Globulins / Q000032:analysis; D013577:Syndrome; D013739:Testosterone / Q000097:blood
D000728:Androgens; D006062:Gonadotropins; D006914:Hydroxysteroids; D012712:Serum Globulins; D002996:Clomiphene; D004970:Estrone; D013739:Testosterone; D004958:Estradiol; D003907:Dexamethasone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008797:Metyrapone